IGFBP4 and obstructive sleep apnea syndrome: Our results indicate a substantial elevation in circulating IGFBP4 levels and hepatic IGFBP4 gene expression in mice exposed to PTFE-induced chronic intermittent hypoxia, simulating OSA conditions.